This article is more than 5 years old. Information may no longer be current.
Biomet and Bonesupport sign distribution agreement
Click Here to Manage Email Alerts
Bonesupport announced the signing of a multi-year exclusive distribution agreement with Biomet Inc. for its propriety Cerament Bone Void Filler product.
The agreement will allow Biomet to distribute the product line in the United States and Canada for orthopedics, trauma and foot and ankle indications. According to a company press release, this agreement is an important step in Bonesupport’s strategy to expand access and accelerate adoption of the Cerament product portfolio.
“In Biomet we have found an experienced partner dedicated to bringing innovative treatments to the world,” Lloyd Diamond, chief executive officer of Bonesupport, stated in the release. “Biomet’s leadership position and strong distribution channel provide full and immediate territory coverage for Cerament in two critical markets, the United States and Canada, and provides an experienced platform from which we can launch future product line extensions.”